Michael H. Carrel

Michael H. Carrel

President and Chief Executive OfficeratAtriCure· In proxies 2021–2025

Pay in FY2025-17% from the year before · AtriCure stock +29.5% the same year

Michael H. Carrel was paid $9.2M in FY2025 (Dec), down 17%. AtriCure stock rose 29.5% that year.

Pay$100 in the stock at the end of FY20 → $71
Pay is from the Summary Compensation Table of each AtriCure proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AtriCurePublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role +7%
  2. AdvaMed®Public company
    • Director? – PresentNo stock prices for these years
  3. Axonics, Inc.Public company · 5 yr
    • Director2019 – 2024 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?